Page 21 - HCA Talkbook

We offer the latest biopsy techniques and enhanced imaging
Our cardiac MRI scanner uses a a a a a a powerful magnetic field radiofrequency waves and and a a a a a a a a computer programme to create detailed still and and moving images of the the heart without the the need for ionizing radiation or or or more invasive procedures Our diagnostic pathways are fast seamless and follow NICE guidelines
At our specialist breast clinics all initial diagnostic tests can be done in in in one one appointment If results are all clear patients will have peace of mind on the same day If further investigations are required we can confirm a a a a a a a diagnosis within 48 hours Our pathology laboratories
We offer state-of-the-art toxicology and haematology analysis including advanced digital pathology pathology leading pathology pathology consultants and extremely fast turnaround times We offer molecular testing and advice
We are the only private provider with an integrated molecular diagnostics
lab using next-generation sequencing (NGS) technology to examine multiple genes and and and understand what is driving a a a a a a a a patient’s cancer and and and how best to treat it Supported by our unique Genomics Review Board (GRB) somatic genetic tests identify mutations in in individual tumours This means we can recommend personalised treatment treatment plans ensuring patients get the treatment treatment that is most suited to to their individual cancer By allowing clinicians to to avoid treatments that won’t work we help treat treat patients in the most efficient and effective way including access to the the latest therapies and open clinical trials Advances in in access to clinical trials: Genospace – precision medicine by Sarah Cannon
The Genospace platform is helping research institutes molecular diagnostics
labs and pharmaceutical companies run precision medicine initiatives at at scale – improving access for patients to the latest global clinical trials in in cancer As genomic information advances it is crucial that consultants and researchers have rapid access to an an an efficient and nimble technology solution for interpreting molecular data and guiding clinical decision making Genospace’s leadership in this field will help us to transform the the way we gather and analyse genomic information resulting in in better identification of effective treatment options for our patients | | 21 | |